Mild Cognitive Impairment Clinical Trial
Official title:
The Effect of Fit Brains Training on Cognitive Performance in Older Adults
The investigators will conduct a 8-week proof-of-concept randomized controlled trial to provide preliminary evidence of efficacy of Fit Brains (Rosetta Stone Canada) training -- a mobile cognitive training program -- on cognitive and brain plasticity in older adults. The investigators will also explore whether Fit Brains training paired with a brief bout of exercise would enhance the potential cognitive benefits of Fit Brains. In addition, the investigators will explore the long-term effects of cognitive training by performing a 1-year follow-up measurement (i.e., 1-year after study completion).
This study will look at the effect of FBT on cognitive function in older adults.
Additionally, the investigators aim to explore whether a single bout of aerobic exercise
prior to Fit Brains training would magnify the training effect on both cognitive and brain
outcomes.
Objectives:
1) To compare the effect of Fit Brains training (FBT) and the effect of a single bout of
aerobic exercise prior to FBT (Ex-FBT) with a Balanced And Tone (BAT; control) program on
cognitive performance in both older adults; 2) To explore the effect of FBT and Ex-FBT with
BAT on brain structure and function i; 3) To explore whether the intervention effects (i.e.,
FBT and Ex-FBT) are moderated by cognitive status (i.e., MCI or not); 4) To explore whether
Ex-FBT has additional benefits compared with FBT; and 5) To explore whether potential
benefits are maintained at 1-year follow-up.
Research Method:
The investigators will conduct an 8-week proof-of-concept, assessor single-blinded randomized
controlled trial (RCT) with 120 older adults (i.e., 40 in each experimental group). A subset
of participants will perform MRI scans at baseline and 8-weeks.
To reduce bias, all assessors will be blinded to group allocation of participants.
Participants will be randomly assigned to one of the three groups (i.e., FBT, Ex-FBT, or
SCT). Participants in the FBT group will be required to attend 3 formal training sessions per
week, for 8 weeks, at the Djavad Mowafaghian Centre for Brain Health or the Centre for Hip
Health and Mobility. Each session will be for 60 minutes. Additionally, the participants will
be asked to complete 3 additional one-hour training sessions at home per week. Thus, the
participants will complete a total of 48 hours of cognitive training over 8 weeks.
Participants who are randomized to Ex-FBT will be required to attend 3 formal training
sessions per week, for 8 weeks, at the Djavad Mowafaghian Centre for Brain Health or Centre
for Hip Health and Mobility. Each session will be for 1 hour. The participants will start the
training with a 15-minute walk outside. The 15-minute walk is followed by a 45-minute FBT
session (FBT program). Additionally, participants will be asked to complete 3 additional
1-hour training sessions at home (i.e., 15-minute walk followed by 45-minutes of FBT
training). Thus, the participants will complete a total of 48 hours of cognitive + walking
training over 8 weeks.
Participants who are randomly assigned to the BAT group will be required to attend 3 formal
training sessions per week, for 8 weeks, at both the Djavad Mowafaghian Centre for Brain
Health and/or the Centre for Hip Health and Mobility. Specifically, the participants will
complete a total of 8 hours of sham cognitive training, 8 hours of sham exercise training
(Centre for Hip Health and Mobility) and 8 hours of education over the 8 weeks. Thus, the
participants will complete a total of 24 hours of sham training over 8 weeks.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04513106 -
Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial
|
N/A | |
| Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
| Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
| Active, not recruiting |
NCT03167840 -
Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment
|
N/A | |
| Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
| Not yet recruiting |
NCT05041790 -
A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
|
Phase 4 | |
| Recruiting |
NCT04121156 -
High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment
|
N/A | |
| Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
| Completed |
NCT02774083 -
Cognitive Training Using Feuerstein Instrumental Enrichment
|
N/A | |
| Completed |
NCT01315639 -
New Biomarker for Alzheimer's Disease Diagnostic
|
N/A | |
| Enrolling by invitation |
NCT06023446 -
Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
|
||
| Completed |
NCT04567745 -
Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers
|
Phase 1 | |
| Recruiting |
NCT05579236 -
Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
|
||
| Completed |
NCT03583879 -
Using Gait Robotics to Improve Symptoms of Parkinson's Disease
|
N/A | |
| Terminated |
NCT02503501 -
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
|
Phase 2 | |
| Not yet recruiting |
NCT03740178 -
Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
|
Phase 1 | |
| Active, not recruiting |
NCT05204940 -
Longitudinal Observational Biomarker Study
|
||
| Recruiting |
NCT02663531 -
Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease
|
N/A | |
| Recruiting |
NCT06150352 -
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
|
||
| Recruiting |
NCT03507192 -
Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.
|
N/A |